date
Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.580339691662088.
The log-likelihood improved by 3.355.
Iteration 2 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 1.14.
Step length converged once. Increasing MCMC sample size.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.2522.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree1  degree2  degree3  degree4  degree5  degree6  degree7  degree8 
      21     1188     1047      772      375      340      402      300 
 degree9 degree10 degree11 degree12 degree13 degree14 degree15 degree16 
     213      154       93       58       23       11        1        1 
degree17 
       1 
1 
disease_progression 
H-positive risk:  866 859 129 864 461 114 896 437 109 73 137 55 
H-negative risk:  859 866 896 864 437 461 114 129 137 109 55 73 
New BC onsets:  0
BC status:  5000 
BC subtype:  5000 

clinical_engagement 
diagnosis 
demography 
57 new agents 
2 
disease_progression 
H-positive risk:  871 862 130 861 467 115 894 430 105 73 136 56 
H-negative risk:  862 871 894 861 430 467 115 130 136 105 56 73 
New BC onsets:  2
BC status:  4998 2 
BC subtype:  4998 2 

clinical_engagement 
diagnosis 
demography 
61 new agents 
3 
disease_progression 
H-positive risk:  876 865 130 856 462 115 895 430 105 72 138 56 
H-negative risk:  865 876 895 856 430 462 115 130 138 105 56 72 
New BC onsets:  6
BC status:  4994 6 
BC subtype:  4994 5 1 

clinical_engagement 
diagnosis 
demography 
68 new agents 
4 
disease_progression 
H-positive risk:  874 874 130 860 454 116 894 428 106 71 137 56 
H-negative risk:  874 874 894 860 428 454 116 130 137 106 56 71 
New BC onsets:  6
BC status:  4994 6 
BC subtype:  4994 5 1 

clinical_engagement 
diagnosis 
demography 
48 new agents 
5 
disease_progression 
H-positive risk:  879 878 132 859 447 116 893 424 109 71 136 56 
H-negative risk:  878 879 893 859 424 447 116 132 136 109 56 71 
New BC onsets:  10
BC status:  4990 10 
BC subtype:  4990 8 2 

clinical_engagement 
diagnosis 
demography 
72 new agents 
6 
disease_progression 
H-positive risk:  891 880 136 860 437 119 894 414 109 72 134 54 
H-negative risk:  880 891 894 860 414 437 119 136 134 109 54 72 
New BC onsets:  11
BC status:  4989 11 
BC subtype:  4989 9 2 

clinical_engagement 
diagnosis 
demography 
63 new agents 
7 
disease_progression 
H-positive risk:  894 890 134 861 431 122 891 411 110 70 131 55 
H-negative risk:  890 894 891 861 411 431 122 134 131 110 55 70 
New BC onsets:  14
BC status:  4986 14 
BC subtype:  4986 11 3 

clinical_engagement 
diagnosis 
demography 
70 new agents 
8 
disease_progression 
H-positive risk:  899 886 135 859 433 126 892 407 110 70 129 54 
H-negative risk:  886 899 892 859 407 433 126 135 129 110 54 70 
New BC onsets:  19
BC status:  4981 19 
BC subtype:  4981 14 5 

clinical_engagement 
diagnosis 
demography 
81 new agents 
9 
disease_progression 
H-positive risk:  901 897 135 860 437 125 879 403 114 68 129 52 
H-negative risk:  897 901 879 860 403 437 125 135 129 114 52 68 
New BC onsets:  20
BC status:  4980 20 
BC subtype:  4980 15 5 

clinical_engagement 
diagnosis 
demography 
66 new agents 
10 
disease_progression 
H-positive risk:  906 906 137 857 427 127 877 400 115 69 128 51 
H-negative risk:  906 906 877 857 400 427 127 137 128 115 51 69 
New BC onsets:  22
BC status:  4978 22 
BC subtype:  4978 15 7 

clinical_engagement 
diagnosis 
demography 
55 new agents 
11 
disease_progression 
H-positive risk:  909 917 136 853 419 130 872 399 117 69 129 50 
H-negative risk:  917 909 872 853 399 419 130 136 129 117 50 69 
New BC onsets:  23
BC status:  4977 23 
BC subtype:  4977 14 9 

clinical_engagement 
diagnosis 
demography 
61 new agents 
12 
disease_progression 
H-positive risk:  912 921 136 853 420 131 865 399 118 67 129 49 
H-negative risk:  921 912 865 853 399 420 131 136 129 118 49 67 
New BC onsets:  26
BC status:  4974 26 
BC subtype:  4974 15 11 

clinical_engagement 
diagnosis 
demography 
69 new agents 
13 
disease_progression 
H-positive risk:  820 846 126 931 415 121 960 396 130 67 138 50 
H-negative risk:  846 820 960 931 396 415 121 126 138 130 50 67 
New BC onsets:  27
BC status:  4973 27 
BC subtype:  4973 16 11 

clinical_engagement 
diagnosis 
demography 
230 new agents 
14 
disease_progression 
H-positive risk:  849 883 131 896 421 125 897 424 126 63 131 54 
H-negative risk:  883 849 897 896 424 421 125 131 131 126 54 63 
New BC onsets:  32
BC status:  4968 32 
BC subtype:  4968 21 11 

clinical_engagement 
diagnosis 
demography 
57 new agents 
15 
disease_progression 
H-positive risk:  850 891 131 899 420 124 888 424 127 64 129 53 
H-negative risk:  891 850 888 899 424 420 124 131 129 127 53 64 
New BC onsets:  33
BC status:  4967 33 
BC subtype:  4967 22 11 

clinical_engagement 
diagnosis 
demography 
78 new agents 
16 
disease_progression 
H-positive risk:  855 902 130 899 421 125 886 415 126 58 129 54 
H-negative risk:  902 855 886 899 415 421 125 130 129 126 54 58 
New BC onsets:  33
BC status:  4967 33 
BC subtype:  4967 22 11 

clinical_engagement 
diagnosis 
demography 
45 new agents 
17 
disease_progression 
H-positive risk:  858 898 132 900 415 127 889 412 126 57 132 54 
H-negative risk:  898 858 889 900 412 415 127 132 132 126 54 57 
New BC onsets:  38
BC status:  4962 38 
BC subtype:  4962 27 11 

clinical_engagement 
diagnosis 
demography 
71 new agents 
18 
disease_progression 
H-positive risk:  858 903 132 902 412 125 888 412 126 58 133 51 
H-negative risk:  903 858 888 902 412 412 125 132 133 126 51 58 
New BC onsets:  43
BC status:  4957 43 
BC subtype:  4957 31 12 

clinical_engagement 
diagnosis 
demography 
50 new agents 
19 
disease_progression 
H-positive risk:  863 907 134 906 412 127 882 404 124 58 133 50 
H-negative risk:  907 863 882 906 404 412 127 134 133 124 50 58 
New BC onsets:  46
BC status:  4954 46 
BC subtype:  4954 34 12 

clinical_engagement 
diagnosis 
demography 
52 new agents 
20 
disease_progression 
H-positive risk:  866 907 132 910 410 126 879 399 129 57 133 52 
H-negative risk:  907 866 879 910 399 410 126 132 133 129 52 57 
New BC onsets:  46
BC status:  4954 46 
BC subtype:  4954 33 13 

clinical_engagement 
diagnosis 
demography 
60 new agents 
21 
disease_progression 
H-positive risk:  873 907 132 908 405 126 879 399 127 57 135 52 
H-negative risk:  907 873 879 908 399 405 126 132 135 127 52 57 
New BC onsets:  48
BC status:  4952 48 
BC subtype:  4952 35 13 

clinical_engagement 
diagnosis 
demography 
65 new agents 
22 
disease_progression 
H-positive risk:  875 908 135 909 399 126 879 396 127 58 137 51 
H-negative risk:  908 875 879 909 396 399 126 135 137 127 51 58 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 34 13 

clinical_engagement 
diagnosis 
demography 
70 new agents 
23 
disease_progression 
H-positive risk:  879 915 133 911 398 126 877 391 125 58 136 51 
H-negative risk:  915 879 877 911 391 398 126 133 136 125 51 58 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 35 12 

clinical_engagement 
diagnosis 
demography 
68 new agents 
24 
disease_progression 
H-positive risk:  878 922 136 906 393 127 885 388 124 56 135 50 
H-negative risk:  922 878 885 906 388 393 127 136 135 124 50 56 
New BC onsets:  46
BC status:  4954 46 
BC subtype:  4954 34 12 

clinical_engagement 
diagnosis 
demography 
51 new agents 
25 
disease_progression 
H-positive risk:  818 847 128 980 387 118 951 388 132 55 144 52 
H-negative risk:  847 818 951 980 388 387 118 128 144 132 52 55 
New BC onsets:  48
BC status:  4952 48 
BC subtype:  4952 35 13 

clinical_engagement 
diagnosis 
demography 
168 new agents 
26 
disease_progression 
H-positive risk:  837 864 133 932 408 123 915 411 125 56 142 54 
H-negative risk:  864 837 915 932 411 408 123 133 142 125 54 56 
New BC onsets:  49
BC status:  4951 49 
BC subtype:  4951 36 13 

clinical_engagement 
diagnosis 
demography 
68 new agents 
27 
disease_progression 
H-positive risk:  841 861 132 928 406 123 917 416 125 54 143 54 
H-negative risk:  861 841 917 928 416 406 123 132 143 125 54 54 
New BC onsets:  49
BC status:  4951 49 
BC subtype:  4951 36 13 

clinical_engagement 
diagnosis 
demography 
56 new agents 
28 
disease_progression 
H-positive risk:  844 866 132 927 402 125 916 412 125 54 141 56 
H-negative risk:  866 844 916 927 412 402 125 132 141 125 56 54 
New BC onsets:  49
BC status:  4951 49 
BC subtype:  4951 35 14 

clinical_engagement 
diagnosis 
demography 
81 new agents 
29 
disease_progression 
H-positive risk:  853 880 133 927 395 126 910 407 124 51 140 54 
H-negative risk:  880 853 910 927 407 395 126 133 140 124 54 51 
New BC onsets:  49
BC status:  4951 49 
BC subtype:  4951 35 14 

clinical_engagement 
diagnosis 
demography 
57 new agents 
30 
disease_progression 
H-positive risk:  864 872 134 925 398 128 911 403 122 51 138 54 
H-negative risk:  872 864 911 925 403 398 128 134 138 122 54 51 
New BC onsets:  50
BC status:  4950 50 
BC subtype:  4950 36 14 

clinical_engagement 
diagnosis 
demography 
49 new agents 
31 
disease_progression 
H-positive risk:  867 880 135 927 388 127 909 399 125 49 141 53 
H-negative risk:  880 867 909 927 399 388 127 135 141 125 53 49 
New BC onsets:  49
BC status:  4951 49 
BC subtype:  4951 35 14 

clinical_engagement 
diagnosis 
demography 
55 new agents 
32 
disease_progression 
H-positive risk:  870 887 134 924 392 127 904 396 123 50 141 52 
H-negative risk:  887 870 904 924 396 392 127 134 141 123 52 50 
New BC onsets:  52
BC status:  4948 52 
BC subtype:  4948 38 14 

clinical_engagement 
diagnosis 
demography 
58 new agents 
33 
disease_progression 
H-positive risk:  876 882 135 925 394 128 903 390 121 52 143 51 
H-negative risk:  882 876 903 925 390 394 128 135 143 121 51 52 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 39 14 

clinical_engagement 
diagnosis 
demography 
60 new agents 
34 
disease_progression 
H-positive risk:  874 892 134 930 390 128 904 384 118 53 144 49 
H-negative risk:  892 874 904 930 384 390 128 134 144 118 49 53 
New BC onsets:  51
BC status:  4949 51 
BC subtype:  4949 37 14 

clinical_engagement 
diagnosis 
demography 
52 new agents 
35 
disease_progression 
H-positive risk:  880 892 133 928 385 126 899 386 125 52 143 51 
H-negative risk:  892 880 899 928 386 385 126 133 143 125 51 52 
New BC onsets:  50
BC status:  4950 50 
BC subtype:  4950 36 14 

clinical_engagement 
diagnosis 
demography 
56 new agents 
36 
disease_progression 
H-positive risk:  878 900 134 929 382 127 905 375 123 53 144 50 
H-negative risk:  900 878 905 929 375 382 127 134 144 123 50 53 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 38 15 

clinical_engagement 
diagnosis 
demography 
66 new agents 
37 
disease_progression 
H-positive risk:  810 841 128 995 381 120 971 369 134 53 150 48 
H-negative risk:  841 810 971 995 369 381 120 128 150 134 48 53 
New BC onsets:  54
BC status:  4946 54 
BC subtype:  4946 39 15 

clinical_engagement 
diagnosis 
demography 
167 new agents 
38 
disease_progression 
H-positive risk:  819 857 131 987 378 117 932 402 137 51 140 49 
H-negative risk:  857 819 932 987 402 378 117 131 140 137 49 51 
New BC onsets:  54
BC status:  4946 54 
BC subtype:  4946 39 15 

clinical_engagement 
diagnosis 
demography 
63 new agents 
39 
disease_progression 
H-positive risk:  822 860 131 986 379 118 929 400 139 52 133 51 
H-negative risk:  860 822 929 986 400 379 118 131 133 139 51 52 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 40 15 

clinical_engagement 
diagnosis 
demography 
58 new agents 
40 
disease_progression 
H-positive risk:  824 860 132 987 382 119 919 403 139 52 130 53 
H-negative risk:  860 824 919 987 403 382 119 132 130 139 53 52 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 42 16 

clinical_engagement 
diagnosis 
demography 
71 new agents 
41 
disease_progression 
H-positive risk:  830 868 131 987 380 121 922 398 135 50 129 49 
H-negative risk:  868 830 922 987 398 380 121 131 129 135 49 50 
New BC onsets:  63
BC status:  4937 63 
BC subtype:  4937 46 17 

clinical_engagement 
diagnosis 
demography 
66 new agents 
42 
disease_progression 
H-positive risk:  828 877 128 985 374 120 922 399 136 49 132 50 
H-negative risk:  877 828 922 985 399 374 120 128 132 136 50 49 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 50 17 

clinical_engagement 
diagnosis 
demography 
67 new agents 
43 
disease_progression 
H-positive risk:  833 878 128 987 370 119 921 398 135 50 132 49 
H-negative risk:  878 833 921 987 398 370 119 128 132 135 49 50 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 54 20 

clinical_engagement 
diagnosis 
demography 
55 new agents 
44 
disease_progression 
H-positive risk:  832 882 130 984 372 120 916 397 137 50 133 47 
H-negative risk:  882 832 916 984 397 372 120 130 133 137 47 50 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 55 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
45 
disease_progression 
H-positive risk:  835 888 131 986 368 118 916 386 140 51 133 48 
H-negative risk:  888 835 916 986 386 368 118 131 133 140 48 51 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 54 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
46 
disease_progression 
H-positive risk:  832 889 131 993 367 117 918 382 139 51 135 46 
H-negative risk:  889 832 918 993 382 367 117 131 135 139 46 51 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 56 22 

clinical_engagement 
diagnosis 
demography 
61 new agents 
47 
disease_progression 
H-positive risk:  833 893 129 991 362 119 917 387 135 50 137 47 
H-negative risk:  893 833 917 991 387 362 119 129 137 135 47 50 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 56 23 

clinical_engagement 
diagnosis 
demography 
63 new agents 
48 
disease_progression 
H-positive risk:  834 888 129 990 369 123 914 388 132 53 131 49 
H-negative risk:  888 834 914 990 388 369 123 129 131 132 49 53 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 54 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
49 
disease_progression 
H-positive risk:  779 832 122 1045 370 112 967 390 144 51 142 46 
H-negative risk:  832 779 967 1045 390 370 112 122 142 144 46 51 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 53 25 

clinical_engagement 
diagnosis 
demography 
145 new agents 
50 
disease_progression 
H-positive risk:  789 847 123 1016 378 114 950 399 143 55 137 49 
H-negative risk:  847 789 950 1016 399 378 114 123 137 143 49 55 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 51 23 

clinical_engagement 
diagnosis 
demography 
95 new agents 
51 
disease_progression 
H-positive risk:  801 854 122 1010 367 114 948 400 140 57 137 50 
H-negative risk:  854 801 948 1010 400 367 114 122 137 140 50 57 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 52 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
52 
disease_progression 
H-positive risk:  801 862 124 1007 372 113 948 400 139 55 134 45 
H-negative risk:  862 801 948 1007 400 372 113 124 134 139 45 55 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 54 24 

clinical_engagement 
diagnosis 
demography 
44 new agents 
53 
disease_progression 
H-positive risk:  802 863 126 1003 376 113 944 399 140 56 133 45 
H-negative risk:  863 802 944 1003 399 376 113 126 133 140 45 56 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 54 25 

clinical_engagement 
diagnosis 
demography 
67 new agents 
54 
disease_progression 
H-positive risk:  809 871 124 1014 368 114 935 390 141 54 135 45 
H-negative risk:  871 809 935 1014 390 368 114 124 135 141 45 54 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 52 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
55 
disease_progression 
H-positive risk:  814 870 125 1010 371 113 939 385 141 53 135 44 
H-negative risk:  870 814 939 1010 385 371 113 125 135 141 44 53 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 55 25 

clinical_engagement 
diagnosis 
demography 
63 new agents 
56 
disease_progression 
H-positive risk:  816 874 125 1012 365 116 936 379 140 55 138 44 
H-negative risk:  874 816 936 1012 379 365 116 125 138 140 44 55 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 53 25 

clinical_engagement 
diagnosis 
demography 
58 new agents 
57 
disease_progression 
H-positive risk:  822 883 126 1014 361 118 927 378 137 54 137 43 
H-negative risk:  883 822 927 1014 378 361 118 126 137 137 43 54 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 55 24 

clinical_engagement 
diagnosis 
demography 
64 new agents 
58 
disease_progression 
H-positive risk:  824 881 128 1018 360 118 931 369 136 54 135 46 
H-negative risk:  881 824 931 1018 369 360 118 128 135 136 46 54 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 60 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
59 
disease_progression 
H-positive risk:  829 883 128 1017 364 118 935 354 134 55 136 47 
H-negative risk:  883 829 935 1017 354 364 118 128 136 134 47 55 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 58 23 

clinical_engagement 
diagnosis 
demography 
65 new agents 
60 
disease_progression 
H-positive risk:  835 883 129 1013 365 118 931 353 133 56 137 47 
H-negative risk:  883 835 931 1013 353 365 118 129 137 133 47 56 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 58 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
61 
disease_progression 
H-positive risk:  789 825 116 1068 358 109 982 355 142 59 150 47 
H-negative risk:  825 789 982 1068 355 358 109 116 150 142 47 59 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 59 23 

clinical_engagement 
diagnosis 
demography 
111 new agents 
62 
disease_progression 
H-positive risk:  783 823 117 1032 395 111 956 385 141 56 147 54 
H-negative risk:  823 783 956 1032 385 395 111 117 147 141 54 56 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 58 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
63 
disease_progression 
H-positive risk:  789 822 122 1031 395 110 949 382 137 60 148 55 
H-negative risk:  822 789 949 1031 382 395 110 122 148 137 55 60 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 58 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
64 
disease_progression 
H-positive risk:  792 825 123 1038 392 110 948 372 141 60 144 55 
H-negative risk:  825 792 948 1038 372 392 110 123 144 141 55 60 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 60 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
65 
disease_progression 
H-positive risk:  804 831 126 1036 391 109 944 367 138 57 145 52 
H-negative risk:  831 804 944 1036 367 391 109 126 145 138 52 57 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 59 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
66 
disease_progression 
H-positive risk:  801 836 128 1042 383 110 936 370 142 58 143 51 
H-negative risk:  836 801 936 1042 370 383 110 128 143 142 51 58 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 58 27 

clinical_engagement 
diagnosis 
demography 
63 new agents 
67 
disease_progression 
H-positive risk:  796 839 129 1049 376 110 938 371 142 57 140 53 
H-negative risk:  839 796 938 1049 371 376 110 129 140 142 53 57 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 58 27 

clinical_engagement 
diagnosis 
demography 
61 new agents 
68 
disease_progression 
H-positive risk:  793 847 129 1048 364 108 947 373 139 57 142 53 
H-negative risk:  847 793 947 1048 373 364 108 129 142 139 53 57 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 56 26 

clinical_engagement 
diagnosis 
demography 
49 new agents 
69 
disease_progression 
H-positive risk:  796 849 128 1042 370 108 949 369 139 55 140 55 
H-negative risk:  849 796 949 1042 369 370 108 128 140 139 55 55 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 56 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
70 
disease_progression 
H-positive risk:  801 850 126 1040 363 108 958 368 139 55 138 54 
H-negative risk:  850 801 958 1040 368 363 108 126 138 139 54 55 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 55 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
71 
disease_progression 
H-positive risk:  796 845 128 1046 368 107 962 367 139 51 136 55 
H-negative risk:  845 796 962 1046 367 368 107 128 136 139 55 51 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 56 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
72 
disease_progression 
H-positive risk:  794 845 127 1048 364 108 966 369 135 53 133 58 
H-negative risk:  845 794 966 1048 369 364 108 127 133 135 58 53 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 57 23 

clinical_engagement 
diagnosis 
demography 
87 new agents 
73 
disease_progression 
H-positive risk:  749 784 123 1100 358 110 1016 370 137 52 142 59 
H-negative risk:  784 749 1016 1100 370 358 110 123 142 137 59 52 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 56 23 

clinical_engagement 
diagnosis 
demography 
129 new agents 
74 
disease_progression 
H-positive risk:  764 785 119 1089 373 109 1006 366 138 53 142 56 
H-negative risk:  785 764 1006 1089 366 373 109 119 142 138 56 53 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 58 23 

clinical_engagement 
diagnosis 
demography 
94 new agents 
75 
disease_progression 
H-positive risk:  774 782 122 1081 385 108 993 369 138 51 141 56 
H-negative risk:  782 774 993 1081 369 385 108 122 141 138 56 51 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 60 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
76 
disease_progression 
H-positive risk:  778 781 120 1083 381 109 998 365 138 51 141 55 
H-negative risk:  781 778 998 1083 365 381 109 120 141 138 55 51 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 59 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
77 
disease_progression 
H-positive risk:  780 787 120 1081 384 109 998 356 137 51 140 57 
H-negative risk:  787 780 998 1081 356 384 109 120 140 137 57 51 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 60 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
78 
disease_progression 
H-positive risk:  772 784 119 1077 386 109 1004 353 144 50 144 58 
H-negative risk:  784 772 1004 1077 353 386 109 119 144 144 58 50 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 60 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
79 
disease_progression 
H-positive risk:  781 781 118 1066 386 110 1008 356 143 49 144 58 
H-negative risk:  781 781 1008 1066 356 386 110 118 144 143 58 49 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 58 23 

clinical_engagement 
diagnosis 
demography 
61 new agents 
80 
disease_progression 
H-positive risk:  779 783 116 1070 382 108 1010 358 144 49 142 59 
H-negative risk:  783 779 1010 1070 358 382 108 116 142 144 59 49 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 63 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
81 
disease_progression 
H-positive risk:  782 791 116 1068 371 109 1018 353 144 49 140 59 
H-negative risk:  791 782 1018 1068 353 371 109 116 140 144 59 49 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 64 25 

clinical_engagement 
diagnosis 
demography 
59 new agents 
82 
disease_progression 
H-positive risk:  784 797 115 1058 376 108 1015 354 145 48 143 57 
H-negative risk:  797 784 1015 1058 354 376 108 115 143 145 57 48 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 64 24 

clinical_engagement 
diagnosis 
demography 
54 new agents 
83 
disease_progression 
H-positive risk:  788 801 119 1058 376 110 1008 351 145 44 142 58 
H-negative risk:  801 788 1008 1058 351 376 110 119 142 145 58 44 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 64 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
84 
disease_progression 
H-positive risk:  796 802 115 1058 378 109 1005 353 144 43 140 57 
H-negative risk:  802 796 1005 1058 353 378 109 115 140 144 57 43 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 64 28 

clinical_engagement 
diagnosis 
demography 
71 new agents 
85 
disease_progression 
H-positive risk:  746 744 101 1106 384 107 1057 356 145 42 154 58 
H-negative risk:  744 746 1057 1106 356 384 107 101 154 145 58 42 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 65 28 

clinical_engagement 
diagnosis 
demography 
104 new agents 
86 
disease_progression 
H-positive risk:  746 743 102 1097 390 106 1051 369 142 43 153 58 
H-negative risk:  743 746 1051 1097 369 390 106 102 153 142 58 43 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 64 28 

clinical_engagement 
diagnosis 
demography 
81 new agents 
87 
disease_progression 
H-positive risk:  752 741 99 1090 393 109 1052 370 140 40 156 58 
H-negative risk:  741 752 1052 1090 370 393 109 99 156 140 58 40 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 62 30 

clinical_engagement 
diagnosis 
demography 
72 new agents 
88 
disease_progression 
H-positive risk:  767 734 97 1084 397 111 1050 365 139 39 158 59 
H-negative risk:  734 767 1050 1084 365 397 111 97 158 139 59 39 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 66 30 

clinical_engagement 
diagnosis 
demography 
74 new agents 
89 
disease_progression 
H-positive risk:  769 736 101 1075 395 109 1052 365 141 37 161 59 
H-negative risk:  736 769 1052 1075 365 395 109 101 161 141 59 37 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 65 37 

clinical_engagement 
diagnosis 
demography 
63 new agents 
90 
disease_progression 
H-positive risk:  765 729 98 1073 389 113 1055 377 141 38 162 60 
H-negative risk:  729 765 1055 1073 377 389 113 98 162 141 60 38 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 68 36 

clinical_engagement 
diagnosis 
demography 
63 new agents 
91 
disease_progression 
H-positive risk:  766 731 96 1077 389 111 1056 378 138 38 160 60 
H-negative risk:  731 766 1056 1077 378 389 111 96 160 138 60 38 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 70 35 

clinical_engagement 
diagnosis 
demography 
71 new agents 
92 
disease_progression 
H-positive risk:  761 724 96 1089 385 113 1059 376 134 41 161 61 
H-negative risk:  724 761 1059 1089 376 385 113 96 161 134 61 41 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 68 35 

clinical_engagement 
diagnosis 
demography 
78 new agents 
93 
disease_progression 
H-positive risk:  765 721 96 1084 381 113 1061 380 137 44 158 60 
H-negative risk:  721 765 1061 1084 380 381 113 96 158 137 60 44 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 69 33 

clinical_engagement 
diagnosis 
demography 
72 new agents 
94 
disease_progression 
H-positive risk:  770 718 97 1086 379 113 1059 377 138 46 158 59 
H-negative risk:  718 770 1059 1086 377 379 113 97 158 138 59 46 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 69 31 

clinical_engagement 
diagnosis 
demography 
72 new agents 
95 
disease_progression 
H-positive risk:  774 730 99 1068 378 114 1060 376 138 43 159 61 
H-negative risk:  730 774 1060 1068 376 378 114 99 159 138 61 43 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 72 30 

clinical_engagement 
diagnosis 
demography 
70 new agents 
96 
disease_progression 
H-positive risk:  773 736 99 1065 375 112 1057 379 137 46 158 63 
H-negative risk:  736 773 1057 1065 379 375 112 99 158 137 63 46 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 71 32 

clinical_engagement 
diagnosis 
demography 
78 new agents 
97 
disease_progression 
H-positive risk:  730 702 92 1093 376 109 1106 372 147 44 170 59 
H-negative risk:  702 730 1106 1093 372 376 109 92 170 147 59 44 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 71 30 

clinical_engagement 
diagnosis 
demography 
104 new agents 
98 
disease_progression 
H-positive risk:  738 701 94 1080 384 105 1094 383 144 45 171 61 
H-negative risk:  701 738 1094 1080 383 384 105 94 171 144 61 45 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 70 31 

clinical_engagement 
diagnosis 
demography 
77 new agents 
99 
disease_progression 
H-positive risk:  749 704 89 1082 380 106 1090 378 144 45 173 60 
H-negative risk:  704 749 1090 1082 378 380 106 89 173 144 60 45 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 66 30 

clinical_engagement 
diagnosis 
demography 
61 new agents 
100 
disease_progression 
H-positive risk:  751 701 93 1089 385 107 1084 371 145 45 170 59 
H-negative risk:  701 751 1084 1089 371 385 107 93 170 145 59 45 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 65 30 

clinical_engagement 
diagnosis 
demography 
73 new agents 
101 
disease_progression 
H-positive risk:  749 704 92 1088 376 108 1095 375 144 44 171 54 
H-negative risk:  704 749 1095 1088 375 376 108 92 171 144 54 44 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 67 31 

clinical_engagement 
diagnosis 
demography 
80 new agents 
102 
disease_progression 
H-positive risk:  749 704 94 1097 366 112 1085 378 143 45 171 56 
H-negative risk:  704 749 1085 1097 378 366 112 94 171 143 56 45 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 67 30 

clinical_engagement 
diagnosis 
demography 
73 new agents 
103 
disease_progression 
H-positive risk:  753 695 95 1096 365 113 1087 379 145 46 170 56 
H-negative risk:  695 753 1087 1096 379 365 113 95 170 145 56 46 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 68 29 

clinical_engagement 
diagnosis 
demography 
91 new agents 
104 
disease_progression 
H-positive risk:  751 706 93 1098 360 109 1094 374 146 46 168 55 
H-negative risk:  706 751 1094 1098 374 360 109 93 168 146 55 46 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 66 28 

clinical_engagement 
diagnosis 
demography 
66 new agents 
105 
disease_progression 
H-positive risk:  750 704 98 1103 363 109 1091 369 146 46 167 54 
H-negative risk:  704 750 1091 1103 369 363 109 98 167 146 54 46 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 68 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
106 
disease_progression 
H-positive risk:  748 710 100 1102 357 110 1094 361 150 45 168 55 
H-negative risk:  710 748 1094 1102 361 357 110 100 168 150 55 45 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 63 29 

clinical_engagement 
diagnosis 
demography 
77 new agents 
107 
disease_progression 
H-positive risk:  745 713 99 1105 365 108 1088 363 148 45 168 53 
H-negative risk:  713 745 1088 1105 363 365 108 99 168 148 53 45 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 60 32 

clinical_engagement 
diagnosis 
demography 
61 new agents 
108 
disease_progression 
H-positive risk:  747 714 99 1101 360 105 1091 366 149 45 170 53 
H-negative risk:  714 747 1091 1101 366 360 105 99 170 149 53 45 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 63 32 

clinical_engagement 
diagnosis 
demography 
72 new agents 
109 
disease_progression 
H-positive risk:  695 679 95 1147 355 97 1141 361 158 44 172 56 
H-negative risk:  679 695 1141 1147 361 355 97 95 172 158 56 44 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 60 31 

clinical_engagement 
diagnosis 
demography 
97 new agents 
110 
disease_progression 
H-positive risk:  687 681 97 1140 365 95 1138 368 156 48 165 60 
H-negative risk:  681 687 1138 1140 368 365 95 97 165 156 60 48 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 68 32 

clinical_engagement 
diagnosis 
demography 
77 new agents 
111 
disease_progression 
H-positive risk:  697 682 95 1136 367 95 1130 373 154 50 162 59 
H-negative risk:  682 697 1130 1136 373 367 95 95 162 154 59 50 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 69 33 

clinical_engagement 
diagnosis 
demography 
64 new agents 
112 
disease_progression 
H-positive risk:  701 687 94 1124 373 92 1124 382 155 51 159 58 
H-negative risk:  687 701 1124 1124 382 373 92 94 159 155 58 51 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 70 33 

clinical_engagement 
diagnosis 
demography 
67 new agents 
113 
disease_progression 
H-positive risk:  710 682 90 1124 377 94 1117 384 155 49 161 57 
H-negative risk:  682 710 1117 1124 384 377 94 90 161 155 57 49 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 69 33 

clinical_engagement 
diagnosis 
demography 
66 new agents 
114 
disease_progression 
H-positive risk:  716 687 89 1117 375 86 1110 389 162 50 162 57 
H-negative risk:  687 716 1110 1117 389 375 86 89 162 162 57 50 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 68 31 

clinical_engagement 
diagnosis 
demography 
73 new agents 
115 
disease_progression 
H-positive risk:  717 691 87 1118 375 87 1106 390 160 52 163 54 
H-negative risk:  691 717 1106 1118 390 375 87 87 163 160 54 52 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 68 29 

clinical_engagement 
diagnosis 
demography 
82 new agents 
116 
disease_progression 
H-positive risk:  717 689 87 1121 378 86 1107 384 163 52 165 51 
H-negative risk:  689 717 1107 1121 384 378 86 87 165 163 51 52 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 68 28 

clinical_engagement 
diagnosis 
demography 
71 new agents 
117 
disease_progression 
H-positive risk:  706 686 89 1123 382 88 1110 384 165 50 169 48 
H-negative risk:  686 706 1110 1123 384 382 88 89 169 165 48 50 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 68 28 

clinical_engagement 
diagnosis 
demography 
66 new agents 
118 
disease_progression 
H-positive risk:  707 682 88 1115 382 88 1119 387 166 48 168 50 
H-negative risk:  682 707 1119 1115 387 382 88 88 168 166 50 48 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 68 27 

clinical_engagement 
diagnosis 
demography 
81 new agents 
119 
disease_progression 
H-positive risk:  711 686 88 1120 373 89 1114 388 167 46 167 51 
H-negative risk:  686 711 1114 1120 388 373 89 88 167 167 51 46 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 69 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
120 
disease_progression 
H-positive risk:  718 692 90 1117 372 87 1111 383 168 46 166 50 
H-negative risk:  692 718 1111 1117 383 372 87 90 166 168 50 46 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 72 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
121 
disease_progression 
H-positive risk:  683 663 84 1155 374 79 1148 382 170 44 170 48 
H-negative risk:  663 683 1148 1155 382 374 79 84 170 170 48 44 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 70 22 

clinical_engagement 
diagnosis 
demography 
101 new agents 
122 
disease_progression 
H-positive risk:  685 650 84 1164 378 83 1142 393 166 43 168 44 
H-negative risk:  650 685 1142 1164 393 378 83 84 168 166 44 43 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 64 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
123 
disease_progression 
H-positive risk:  688 650 82 1160 377 85 1136 397 166 44 169 46 
H-negative risk:  650 688 1136 1160 397 377 85 82 169 166 46 44 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 64 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
124 
disease_progression 
H-positive risk:  685 655 83 1155 380 87 1146 390 167 43 167 42 
H-negative risk:  655 685 1146 1155 390 380 87 83 167 167 42 43 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 64 23 

clinical_engagement 
diagnosis 
demography 
88 new agents 
125 
disease_progression 
H-positive risk:  687 658 78 1164 373 88 1143 389 170 41 170 39 
H-negative risk:  658 687 1143 1164 389 373 88 78 170 170 39 41 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 66 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
126 
disease_progression 
H-positive risk:  685 667 79 1163 367 87 1148 383 170 42 169 40 
H-negative risk:  667 685 1148 1163 383 367 87 79 169 170 40 42 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 65 24 

clinical_engagement 
diagnosis 
demography 
56 new agents 
127 
disease_progression 
H-positive risk:  681 662 82 1163 372 88 1147 383 168 42 170 42 
H-negative risk:  662 681 1147 1163 383 372 88 82 170 168 42 42 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 66 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
128 
disease_progression 
H-positive risk:  683 665 83 1156 385 87 1142 380 169 42 169 39 
H-negative risk:  665 683 1142 1156 380 385 87 83 169 169 39 42 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 63 25 

clinical_engagement 
diagnosis 
demography 
81 new agents 
129 
disease_progression 
H-positive risk:  686 670 82 1155 384 90 1138 376 169 41 168 41 
H-negative risk:  670 686 1138 1155 376 384 90 82 168 169 41 41 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 61 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
130 
disease_progression 
H-positive risk:  687 670 83 1150 384 90 1142 378 170 41 165 40 
H-negative risk:  670 687 1142 1150 378 384 90 83 165 170 40 41 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 62 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
131 
disease_progression 
H-positive risk:  692 676 82 1157 378 85 1142 375 171 40 163 39 
H-negative risk:  676 692 1142 1157 375 378 85 82 163 171 39 40 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 64 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
132 
disease_progression 
H-positive risk:  697 678 84 1151 377 86 1137 375 170 42 163 40 
H-negative risk:  678 697 1137 1151 375 377 86 84 163 170 40 42 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 63 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
133 
disease_progression 
H-positive risk:  689 686 84 1156 374 86 1134 380 167 43 159 42 
H-negative risk:  686 689 1134 1156 380 374 86 84 159 167 42 43 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 64 24 

clinical_engagement 
diagnosis 
demography 
91 new agents 
134 
disease_progression 
H-positive risk:  678 685 82 1160 379 82 1124 393 169 44 155 49 
H-negative risk:  685 678 1124 1160 393 379 82 82 155 169 49 44 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 66 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
135 
disease_progression 
H-positive risk:  682 682 84 1163 373 81 1126 395 172 40 153 49 
H-negative risk:  682 682 1126 1163 395 373 81 84 153 172 49 40 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 66 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
136 
disease_progression 
H-positive risk:  677 678 87 1163 388 79 1127 386 173 40 154 48 
H-negative risk:  678 677 1127 1163 386 388 79 87 154 173 48 40 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 67 23 

clinical_engagement 
diagnosis 
demography 
66 new agents 
137 
disease_progression 
H-positive risk:  676 674 86 1160 390 76 1138 375 178 40 157 50 
H-negative risk:  674 676 1138 1160 375 390 76 86 157 178 50 40 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 67 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
138 
disease_progression 
H-positive risk:  672 669 86 1157 390 78 1144 383 176 39 156 50 
H-negative risk:  669 672 1144 1157 383 390 78 86 156 176 50 39 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 68 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
139 
disease_progression 
H-positive risk:  670 674 87 1157 391 78 1143 381 172 40 156 51 
H-negative risk:  674 670 1143 1157 381 391 78 87 156 172 51 40 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 70 23 

clinical_engagement 
diagnosis 
demography 
52 new agents 
140 
disease_progression 
H-positive risk:  671 672 87 1169 390 78 1140 376 168 41 155 53 
H-negative risk:  672 671 1140 1169 376 390 78 87 155 168 53 41 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 72 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
141 
disease_progression 
H-positive risk:  673 675 90 1160 384 77 1149 371 170 40 151 60 
H-negative risk:  675 673 1149 1160 371 384 77 90 151 170 60 40 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
142 
disease_progression 
H-positive risk:  681 683 91 1161 379 79 1149 362 166 41 149 59 
H-negative risk:  683 681 1149 1161 362 379 79 91 149 166 59 41 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
81 new agents 
143 
disease_progression 
H-positive risk:  682 683 88 1160 381 79 1142 370 163 44 147 61 
H-negative risk:  683 682 1142 1160 370 381 79 88 147 163 61 44 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
144 
disease_progression 
H-positive risk:  676 681 90 1168 376 80 1150 364 161 44 148 62 
H-negative risk:  681 676 1150 1168 364 376 80 90 148 161 62 44 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 74 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
145 
disease_progression 
H-positive risk:  668 676 89 1167 379 80 1161 361 164 44 148 63 
H-negative risk:  676 668 1161 1167 361 379 80 89 148 164 63 44 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 74 26 

clinical_engagement 
diagnosis 
demography 
111 new agents 
146 
disease_progression 
H-positive risk:  665 680 91 1168 379 83 1144 373 164 47 145 61 
H-negative risk:  680 665 1144 1168 373 379 83 91 145 164 61 47 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 73 28 

clinical_engagement 
diagnosis 
demography 
86 new agents 
147 
disease_progression 
H-positive risk:  665 675 91 1162 384 84 1145 371 167 47 143 66 
H-negative risk:  675 665 1145 1162 371 384 84 91 143 167 66 47 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 73 30 

clinical_engagement 
diagnosis 
demography 
73 new agents 
148 
disease_progression 
H-positive risk:  662 663 93 1164 384 84 1157 367 166 47 144 69 
H-negative risk:  663 662 1157 1164 367 384 84 93 144 166 69 47 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 74 29 

clinical_engagement 
diagnosis 
demography 
70 new agents 
149 
disease_progression 
H-positive risk:  656 657 95 1163 383 89 1161 370 165 48 142 71 
H-negative risk:  657 656 1161 1163 370 383 89 95 142 165 71 48 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 75 29 

clinical_engagement 
diagnosis 
demography 
77 new agents 
150 
disease_progression 
H-positive risk:  658 664 95 1145 388 89 1163 370 164 48 145 71 
H-negative risk:  664 658 1163 1145 370 388 89 95 145 164 71 48 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 76 30 

clinical_engagement 
diagnosis 
demography 
89 new agents 
151 
disease_progression 
H-positive risk:  655 669 97 1141 389 91 1160 372 165 48 140 73 
H-negative risk:  669 655 1160 1141 372 389 91 97 140 165 73 48 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 77 29 

clinical_engagement 
diagnosis 
demography 
75 new agents 
152 
disease_progression 
H-positive risk:  647 678 100 1151 380 94 1157 372 165 48 140 68 
H-negative risk:  678 647 1157 1151 372 380 94 100 140 165 68 48 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 78 28 

clinical_engagement 
diagnosis 
demography 
80 new agents 
153 
disease_progression 
H-positive risk:  645 674 98 1159 379 95 1157 373 162 45 143 70 
H-negative risk:  674 645 1157 1159 373 379 95 98 143 162 70 45 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 79 27 

clinical_engagement 
diagnosis 
demography 
61 new agents 
154 
disease_progression 
H-positive risk:  640 667 98 1158 390 95 1165 371 160 44 143 69 
H-negative risk:  667 640 1165 1158 371 390 95 98 143 160 69 44 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 79 27 

clinical_engagement 
diagnosis 
demography 
71 new agents 
155 
disease_progression 
H-positive risk:  633 661 100 1162 396 94 1165 375 158 43 144 69 
H-negative risk:  661 633 1165 1162 375 396 94 100 144 158 69 43 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
91 new agents 
156 
disease_progression 
H-positive risk:  627 671 98 1161 387 92 1170 379 160 44 146 65 
H-negative risk:  671 627 1170 1161 379 387 92 98 146 160 65 44 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
157 
disease_progression 
H-positive risk:  630 671 97 1160 386 96 1169 373 161 46 145 66 
H-negative risk:  671 630 1169 1160 373 386 96 97 145 161 66 46 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 91 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
158 
disease_progression 
H-positive risk:  637 667 95 1150 399 97 1140 391 159 49 145 71 
H-negative risk:  667 637 1140 1150 391 399 97 95 145 159 71 49 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 90 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
159 
disease_progression 
H-positive risk:  638 661 97 1147 404 97 1133 401 158 50 145 69 
H-negative risk:  661 638 1133 1147 401 404 97 97 145 158 69 50 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
65 new agents 
160 
disease_progression 
H-positive risk:  638 657 99 1148 408 96 1126 404 161 51 146 66 
H-negative risk:  657 638 1126 1148 404 408 96 99 146 161 66 51 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
90 new agents 
161 
disease_progression 
H-positive risk:  634 665 99 1140 414 98 1128 403 161 50 144 64 
H-negative risk:  665 634 1128 1140 403 414 98 99 144 161 64 50 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
162 
disease_progression 
H-positive risk:  643 671 98 1138 410 96 1126 399 165 51 142 61 
H-negative risk:  671 643 1126 1138 399 410 96 98 142 165 61 51 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
163 
disease_progression 
H-positive risk:  645 673 96 1132 405 95 1128 406 166 52 143 59 
H-negative risk:  673 645 1128 1132 406 405 95 96 143 166 59 52 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
81 new agents 
164 
disease_progression 
H-positive risk:  649 671 93 1130 402 94 1134 405 168 50 145 59 
H-negative risk:  671 649 1134 1130 405 402 94 93 145 168 59 50 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
165 
disease_progression 
H-positive risk:  652 666 92 1130 402 93 1137 407 172 49 142 58 
H-negative risk:  666 652 1137 1130 407 402 93 92 142 172 58 49 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 84 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
166 
disease_progression 
H-positive risk:  644 668 96 1123 402 93 1144 408 171 52 141 58 
H-negative risk:  668 644 1144 1123 408 402 93 96 141 171 58 52 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
167 
disease_progression 
H-positive risk:  639 659 95 1134 397 94 1146 416 168 51 142 59 
H-negative risk:  659 639 1146 1134 416 397 94 95 142 168 59 51 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
88 new agents 
168 
disease_progression 
H-positive risk:  650 659 93 1139 396 94 1146 409 165 50 143 56 
H-negative risk:  659 650 1146 1139 409 396 94 93 143 165 56 50 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
169 
disease_progression 
H-positive risk:  655 655 94 1136 399 94 1140 405 167 52 144 59 
H-negative risk:  655 655 1140 1136 405 399 94 94 144 167 59 52 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
94 new agents 
170 
disease_progression 
H-positive risk:  665 653 93 1135 407 97 1110 413 166 52 149 60 
H-negative risk:  653 665 1110 1135 413 407 97 93 149 166 60 52 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
171 
disease_progression 
H-positive risk:  666 654 96 1126 411 98 1111 415 160 56 149 58 
H-negative risk:  654 666 1111 1126 415 411 98 96 149 160 58 56 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
172 
disease_progression 
H-positive risk:  667 658 96 1115 416 98 1112 412 161 56 150 59 
H-negative risk:  658 667 1112 1115 412 416 98 96 150 161 59 56 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
81 new agents 
173 
disease_progression 
H-positive risk:  661 660 100 1116 416 95 1116 412 160 55 152 57 
H-negative risk:  660 661 1116 1116 412 416 95 100 152 160 57 55 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
174 
disease_progression 
H-positive risk:  660 663 98 1117 414 96 1115 412 159 56 153 57 
H-negative risk:  663 660 1115 1117 412 414 96 98 153 159 57 56 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
175 
disease_progression 
H-positive risk:  656 659 96 1116 412 96 1127 415 158 57 154 54 
H-negative risk:  659 656 1127 1116 415 412 96 96 154 158 54 57 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
176 
disease_progression 
H-positive risk:  663 656 97 1118 412 96 1120 417 159 55 153 54 
H-negative risk:  656 663 1120 1118 417 412 96 97 153 159 54 55 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
177 
disease_progression 
H-positive risk:  666 656 96 1112 406 96 1119 424 155 60 156 54 
H-negative risk:  656 666 1119 1112 424 406 96 96 156 155 54 60 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
178 
disease_progression 
H-positive risk:  666 655 96 1114 406 96 1112 425 160 61 155 54 
H-negative risk:  655 666 1112 1114 425 406 96 96 155 160 54 61 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
92 new agents 
179 
disease_progression 
H-positive risk:  667 655 99 1117 405 98 1114 415 160 63 154 53 
H-negative risk:  655 667 1114 1117 415 405 98 99 154 160 53 63 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
90 new agents 
180 
disease_progression 
H-positive risk:  667 651 103 1118 411 96 1119 411 158 63 150 53 
H-negative risk:  651 667 1119 1118 411 411 96 103 150 158 53 63 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
181 
disease_progression 
H-positive risk:  663 649 103 1116 410 99 1124 413 157 62 151 53 
H-negative risk:  649 663 1124 1116 413 410 99 103 151 157 53 62 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 89 24 

clinical_engagement 
diagnosis 
demography 
64 new agents 
182 
disease_progression 
H-positive risk:  664 640 101 1112 424 97 1109 422 158 65 153 55 
H-negative risk:  640 664 1109 1112 422 424 97 101 153 158 55 65 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
183 
disease_progression 
H-positive risk:  661 644 100 1104 432 93 1107 424 161 65 157 52 
H-negative risk:  644 661 1107 1104 424 432 93 100 157 161 52 65 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 91 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
184 
disease_progression 
H-positive risk:  659 643 100 1102 428 94 1109 423 162 66 159 55 
H-negative risk:  643 659 1109 1102 423 428 94 100 159 162 55 66 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 91 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
185 
disease_progression 
H-positive risk:  661 643 98 1097 427 93 1112 430 162 65 157 55 
H-negative risk:  643 661 1112 1097 430 427 93 98 157 162 55 65 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 93 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
186 
disease_progression 
H-positive risk:  667 640 99 1101 425 95 1105 430 162 64 158 54 
H-negative risk:  640 667 1105 1101 430 425 95 99 158 162 54 64 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 93 22 

clinical_engagement 
diagnosis 
demography 
84 new agents 
187 
disease_progression 
H-positive risk:  679 644 99 1095 437 96 1097 424 163 62 153 51 
H-negative risk:  644 679 1097 1095 424 437 96 99 153 163 51 62 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 94 21 

clinical_engagement 
diagnosis 
demography 
68 new agents 
188 
disease_progression 
H-positive risk:  680 638 101 1094 439 96 1103 424 162 61 151 51 
H-negative risk:  638 680 1103 1094 424 439 96 101 151 162 51 61 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 94 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
189 
disease_progression 
H-positive risk:  686 632 104 1090 442 97 1100 431 160 58 148 52 
H-negative risk:  632 686 1100 1090 431 442 97 104 148 160 52 58 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 92 19 

clinical_engagement 
diagnosis 
demography 
70 new agents 
190 
disease_progression 
H-positive risk:  684 622 104 1103 441 99 1103 431 157 60 145 51 
H-negative risk:  622 684 1103 1103 431 441 99 104 145 157 51 60 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 91 17 

clinical_engagement 
diagnosis 
demography 
82 new agents 
191 
disease_progression 
H-positive risk:  682 628 106 1107 442 102 1098 430 153 60 143 49 
H-negative risk:  628 682 1098 1107 430 442 102 106 143 153 49 60 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 94 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
192 
disease_progression 
H-positive risk:  687 623 106 1106 445 102 1100 424 154 59 144 50 
H-negative risk:  623 687 1100 1106 424 445 102 106 144 154 50 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 92 17 

clinical_engagement 
diagnosis 
demography 
66 new agents 
193 
disease_progression 
H-positive risk:  690 623 111 1100 445 102 1102 422 154 57 145 49 
H-negative risk:  623 690 1102 1100 422 445 102 111 145 154 49 57 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 92 18 

clinical_engagement 
diagnosis 
demography 
90 new agents 
194 
disease_progression 
H-positive risk:  677 628 110 1105 443 101 1099 429 154 59 147 48 
H-negative risk:  628 677 1099 1105 429 443 101 110 147 154 48 59 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 96 18 

clinical_engagement 
diagnosis 
demography 
81 new agents 
195 
disease_progression 
H-positive risk:  681 626 110 1103 445 100 1102 425 152 58 146 52 
H-negative risk:  626 681 1102 1103 425 445 100 110 146 152 52 58 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 96 18 

clinical_engagement 
diagnosis 
demography 
85 new agents 
196 
disease_progression 
H-positive risk:  679 628 110 1099 447 99 1103 422 153 61 149 50 
H-negative risk:  628 679 1103 1099 422 447 99 110 149 153 50 61 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 93 19 

clinical_engagement 
diagnosis 
demography 
92 new agents 
197 
disease_progression 
H-positive risk:  683 632 108 1091 438 101 1106 426 148 62 151 54 
H-negative risk:  632 683 1106 1091 426 438 101 108 151 148 54 62 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 89 18 

clinical_engagement 
diagnosis 
demography 
82 new agents 
198 
disease_progression 
H-positive risk:  695 628 107 1090 436 100 1099 424 150 63 154 54 
H-negative risk:  628 695 1099 1090 424 436 100 107 154 150 54 63 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 88 18 

clinical_engagement 
diagnosis 
demography 
81 new agents 
199 
disease_progression 
H-positive risk:  701 625 110 1085 435 101 1102 422 149 62 153 55 
H-negative risk:  625 701 1102 1085 422 435 101 110 153 149 55 62 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 90 17 

clinical_engagement 
diagnosis 
demography 
72 new agents 
200 
disease_progression 
H-positive risk:  709 625 111 1083 436 99 1087 430 151 62 152 55 
H-negative risk:  625 709 1087 1083 430 436 99 111 152 151 55 62 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 89 18 

clinical_engagement 
diagnosis 
demography 
78 new agents 
201 
disease_progression 
H-positive risk:  705 632 113 1082 436 98 1087 427 155 60 152 53 
H-negative risk:  632 705 1087 1082 427 436 98 113 152 155 53 60 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 89 18 

clinical_engagement 
diagnosis 
demography 
58 new agents 
202 
disease_progression 
H-positive risk:  705 632 114 1079 435 98 1084 432 156 61 151 53 
H-negative risk:  632 705 1084 1079 432 435 98 114 151 156 53 61 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 88 18 

clinical_engagement 
diagnosis 
demography 
75 new agents 
203 
disease_progression 
H-positive risk:  709 631 113 1084 437 98 1081 428 156 61 151 51 
H-negative risk:  631 709 1081 1084 428 437 98 113 151 156 51 61 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 88 18 

clinical_engagement 
diagnosis 
demography 
76 new agents 
204 
disease_progression 
H-positive risk:  705 636 114 1095 428 98 1078 427 155 61 149 54 
H-negative risk:  636 705 1078 1095 427 428 98 114 149 155 54 61 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
205 
disease_progression 
H-positive risk:  706 639 117 1093 423 101 1074 425 151 67 147 57 
H-negative risk:  639 706 1074 1093 425 423 101 117 147 151 57 67 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 89 20 

clinical_engagement 
diagnosis 
demography 
82 new agents 
206 
disease_progression 
H-positive risk:  707 646 117 1084 432 99 1068 426 151 70 142 58 
H-negative risk:  646 707 1068 1084 426 432 99 117 142 151 58 70 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
87 new agents 
207 
disease_progression 
H-positive risk:  709 653 115 1081 428 96 1063 428 156 72 140 59 
H-negative risk:  653 709 1063 1081 428 428 96 115 140 156 59 72 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
208 
disease_progression 
H-positive risk:  710 656 114 1070 438 98 1064 423 158 69 141 59 
H-negative risk:  656 710 1064 1070 423 438 98 114 141 158 59 69 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
67 new agents 
209 
disease_progression 
H-positive risk:  708 653 112 1068 441 97 1068 424 157 70 143 59 
H-negative risk:  653 708 1068 1068 424 441 97 112 143 157 59 70 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
82 new agents 
210 
disease_progression 
H-positive risk:  698 653 110 1075 449 97 1071 430 156 67 140 54 
H-negative risk:  653 698 1071 1075 430 449 97 110 140 156 54 67 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
211 
disease_progression 
H-positive risk:  688 650 108 1084 442 96 1078 436 158 67 137 56 
H-negative risk:  650 688 1078 1084 436 442 96 108 137 158 56 67 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
212 
disease_progression 
H-positive risk:  694 648 109 1079 439 93 1074 439 161 65 142 57 
H-negative risk:  648 694 1074 1079 439 439 93 109 142 161 57 65 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
83 new agents 
213 
disease_progression 
H-positive risk:  706 654 112 1070 440 92 1065 439 162 64 142 54 
H-negative risk:  654 706 1065 1070 439 440 92 112 142 162 54 64 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
214 
disease_progression 
H-positive risk:  711 653 113 1075 431 95 1064 442 160 62 140 54 
H-negative risk:  653 711 1064 1075 442 431 95 113 140 160 54 62 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
215 
disease_progression 
H-positive risk:  710 651 115 1074 423 96 1075 439 158 65 140 54 
H-negative risk:  651 710 1075 1074 439 423 96 115 140 158 54 65 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
62 new agents 
216 
disease_progression 
H-positive risk:  709 644 116 1084 418 95 1079 438 156 67 143 51 
H-negative risk:  644 709 1079 1084 438 418 95 116 143 156 51 67 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
64 new agents 
217 
disease_progression 
H-positive risk:  711 646 114 1085 430 93 1060 446 155 66 141 53 
H-negative risk:  646 711 1060 1085 446 430 93 114 141 155 53 66 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 75 23 

clinical_engagement 
diagnosis 
demography 
93 new agents 
218 
disease_progression 
H-positive risk:  699 649 116 1096 425 92 1065 444 152 66 141 55 
H-negative risk:  649 699 1065 1096 444 425 92 116 141 152 55 66 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
219 
disease_progression 
H-positive risk:  693 651 116 1093 419 90 1078 440 156 65 143 56 
H-negative risk:  651 693 1078 1093 440 419 90 116 143 156 56 65 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 72 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
220 
disease_progression 
H-positive risk:  695 650 115 1088 420 93 1075 450 155 64 143 52 
H-negative risk:  650 695 1075 1088 450 420 93 115 143 155 52 64 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 71 23 

clinical_engagement 
diagnosis 
demography 
81 new agents 
221 
disease_progression 
H-positive risk:  695 646 116 1098 434 90 1062 448 155 65 142 49 
H-negative risk:  646 695 1062 1098 448 434 90 116 142 155 49 65 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 72 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
222 
disease_progression 
H-positive risk:  697 649 119 1102 435 87 1061 442 154 65 140 49 
H-negative risk:  649 697 1061 1102 442 435 87 119 140 154 49 65 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 73 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
223 
disease_progression 
H-positive risk:  696 643 117 1102 436 85 1066 445 158 64 141 47 
H-negative risk:  643 696 1066 1102 445 436 85 117 141 158 47 64 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 72 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
224 
disease_progression 
H-positive risk:  697 642 115 1097 434 87 1073 452 152 63 142 46 
H-negative risk:  642 697 1073 1097 452 434 87 115 142 152 46 63 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 71 23 

clinical_engagement 
diagnosis 
demography 
84 new agents 
225 
disease_progression 
H-positive risk:  694 645 114 1091 435 88 1074 448 154 65 145 47 
H-negative risk:  645 694 1074 1091 448 435 88 114 145 154 47 65 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 75 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
226 
disease_progression 
H-positive risk:  694 646 112 1087 435 86 1067 457 158 64 148 46 
H-negative risk:  646 694 1067 1087 457 435 86 112 148 158 46 64 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
64 new agents 
227 
disease_progression 
H-positive risk:  694 653 110 1079 437 86 1068 451 160 61 153 48 
H-negative risk:  653 694 1068 1079 451 437 86 110 153 160 48 61 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
228 
disease_progression 
H-positive risk:  691 651 107 1078 441 86 1077 446 159 60 155 49 
H-negative risk:  651 691 1077 1078 446 441 86 107 155 159 49 60 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 72 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
229 
disease_progression 
H-positive risk:  684 647 112 1066 445 92 1073 458 159 59 152 53 
H-negative risk:  647 684 1073 1066 458 445 92 112 152 159 53 59 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
86 new agents 
230 
disease_progression 
H-positive risk:  683 652 111 1066 445 94 1067 452 159 61 158 52 
H-negative risk:  652 683 1067 1066 452 445 94 111 158 159 52 61 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 70 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
231 
disease_progression 
H-positive risk:  679 654 111 1062 452 93 1067 456 156 65 156 49 
H-negative risk:  654 679 1067 1062 456 452 93 111 156 156 49 65 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 70 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
232 
disease_progression 
H-positive risk:  675 653 111 1055 449 95 1071 467 154 64 156 50 
H-negative risk:  653 675 1071 1055 467 449 95 111 156 154 50 64 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 77 27 

clinical_engagement 
diagnosis 
demography 
86 new agents 
233 
disease_progression 
H-positive risk:  683 651 110 1053 450 97 1065 466 153 63 159 50 
H-negative risk:  651 683 1065 1053 466 450 97 110 159 153 50 63 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 77 27 

clinical_engagement 
diagnosis 
demography 
70 new agents 
234 
disease_progression 
H-positive risk:  692 652 108 1058 445 97 1062 464 152 63 159 48 
H-negative risk:  652 692 1062 1058 464 445 97 108 159 152 48 63 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 73 28 

clinical_engagement 
diagnosis 
demography 
84 new agents 
235 
disease_progression 
H-positive risk:  700 647 109 1060 437 97 1071 464 147 66 156 46 
H-negative risk:  647 700 1071 1060 464 437 97 109 156 147 46 66 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 69 27 

clinical_engagement 
diagnosis 
demography 
76 new agents 
236 
disease_progression 
H-positive risk:  706 650 107 1057 439 95 1076 456 148 65 154 47 
H-negative risk:  650 706 1076 1057 456 439 95 107 154 148 47 65 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 70 30 

clinical_engagement 
diagnosis 
demography 
81 new agents 
237 
disease_progression 
H-positive risk:  697 661 105 1041 446 96 1084 455 148 64 156 47 
H-negative risk:  661 697 1084 1041 455 446 96 105 156 148 47 64 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 67 31 

clinical_engagement 
diagnosis 
demography 
73 new agents 
238 
disease_progression 
H-positive risk:  698 659 108 1039 447 97 1084 447 151 63 160 47 
H-negative risk:  659 698 1084 1039 447 447 97 108 160 151 47 63 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 67 31 

clinical_engagement 
diagnosis 
demography 
67 new agents 
239 
disease_progression 
H-positive risk:  696 655 109 1039 452 99 1079 454 151 62 158 46 
H-negative risk:  655 696 1079 1039 454 452 99 109 158 151 46 62 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 69 31 

clinical_engagement 
diagnosis 
demography 
90 new agents 
240 
disease_progression 
H-positive risk:  700 653 107 1038 447 97 1079 461 154 62 154 48 
H-negative risk:  653 700 1079 1038 461 447 97 107 154 154 48 62 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 67 31 

clinical_engagement 
diagnosis 
demography 
73 new agents 
241 
disease_progression 
H-positive risk:  697 654 106 1039 449 98 1080 462 151 64 152 48 
H-negative risk:  654 697 1080 1039 462 449 98 106 152 151 48 64 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 69 31 

clinical_engagement 
diagnosis 
demography 
64 new agents 
242 
disease_progression 
H-positive risk:  694 646 110 1042 448 98 1081 465 152 63 155 46 
H-negative risk:  646 694 1081 1042 465 448 98 110 155 152 46 63 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 68 30 

clinical_engagement 
diagnosis 
demography 
71 new agents 
243 
disease_progression 
H-positive risk:  691 648 109 1046 445 99 1080 468 149 64 155 46 
H-negative risk:  648 691 1080 1046 468 445 99 109 155 149 46 64 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 68 31 

clinical_engagement 
diagnosis 
demography 
95 new agents 
244 
disease_progression 
H-positive risk:  694 647 110 1041 439 100 1080 471 153 65 156 44 
H-negative risk:  647 694 1080 1041 471 439 100 110 156 153 44 65 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 71 32 

clinical_engagement 
diagnosis 
demography 
87 new agents 
245 
disease_progression 
H-positive risk:  696 648 110 1038 440 102 1079 470 155 62 155 45 
H-negative risk:  648 696 1079 1038 470 440 102 110 155 155 45 62 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 70 33 

clinical_engagement 
diagnosis 
demography 
74 new agents 
246 
disease_progression 
H-positive risk:  692 646 111 1041 434 99 1086 465 159 65 155 47 
H-negative risk:  646 692 1086 1041 465 434 99 111 155 159 47 65 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 71 36 

clinical_engagement 
diagnosis 
demography 
89 new agents 
247 
disease_progression 
H-positive risk:  693 652 110 1033 433 99 1086 468 156 64 158 48 
H-negative risk:  652 693 1086 1033 468 433 99 110 158 156 48 64 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 73 36 

clinical_engagement 
diagnosis 
demography 
94 new agents 
248 
disease_progression 
H-positive risk:  688 656 111 1039 431 99 1084 461 159 69 156 47 
H-negative risk:  656 688 1084 1039 461 431 99 111 156 159 47 69 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 74 34 

clinical_engagement 
diagnosis 
demography 
73 new agents 
249 
disease_progression 
H-positive risk:  686 655 111 1040 429 100 1085 464 155 70 157 48 
H-negative risk:  655 686 1085 1040 464 429 100 111 157 155 48 70 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 76 33 

clinical_engagement 
diagnosis 
demography 
68 new agents 
250 
disease_progression 
H-positive risk:  691 654 109 1040 440 99 1087 455 153 68 158 46 
H-negative risk:  654 691 1087 1040 455 440 99 109 158 153 46 68 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 76 32 

clinical_engagement 
diagnosis 
demography 
65 new agents 
251 
disease_progression 
H-positive risk:  692 650 106 1051 426 99 1092 457 153 66 159 49 
H-negative risk:  650 692 1092 1051 457 426 99 106 159 153 49 66 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 77 32 

clinical_engagement 
diagnosis 
demography 
74 new agents 
252 
disease_progression 
H-positive risk:  689 653 105 1050 421 99 1101 452 151 66 162 51 
H-negative risk:  653 689 1101 1050 452 421 99 105 162 151 51 66 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 78 30 

clinical_engagement 
diagnosis 
demography 
74 new agents 
253 
disease_progression 
H-positive risk:  687 653 107 1057 423 98 1102 442 155 65 162 49 
H-negative risk:  653 687 1102 1057 442 423 98 107 162 155 49 65 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 82 29 

clinical_engagement 
diagnosis 
demography 
79 new agents 
254 
disease_progression 
H-positive risk:  686 659 105 1067 415 96 1106 430 156 64 163 53 
H-negative risk:  659 686 1106 1067 430 415 96 105 163 156 53 64 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 83 30 

clinical_engagement 
diagnosis 
demography 
90 new agents 
255 
disease_progression 
H-positive risk:  685 667 104 1071 408 96 1109 427 152 63 164 54 
H-negative risk:  667 685 1109 1071 427 408 96 104 164 152 54 63 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 84 30 

clinical_engagement 
diagnosis 
demography 
96 new agents 
256 
disease_progression 
H-positive risk:  686 675 104 1072 404 96 1101 428 154 62 166 52 
H-negative risk:  675 686 1101 1072 428 404 96 104 166 154 52 62 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 83 29 

clinical_engagement 
diagnosis 
demography 
72 new agents 
257 
disease_progression 
H-positive risk:  683 682 104 1063 410 94 1109 425 150 63 168 49 
H-negative risk:  682 683 1109 1063 425 410 94 104 168 150 49 63 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 83 30 

clinical_engagement 
diagnosis 
demography 
71 new agents 
258 
disease_progression 
H-positive risk:  681 685 106 1052 414 94 1104 432 150 65 169 48 
H-negative risk:  685 681 1104 1052 432 414 94 106 169 150 48 65 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 83 32 

clinical_engagement 
diagnosis 
demography 
78 new agents 
259 
disease_progression 
H-positive risk:  690 681 108 1047 415 97 1098 429 149 69 169 48 
H-negative risk:  681 690 1098 1047 429 415 97 108 169 149 48 69 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 84 32 

clinical_engagement 
diagnosis 
demography 
70 new agents 
260 
disease_progression 
H-positive risk:  697 678 106 1042 420 98 1086 436 147 71 170 49 
H-negative risk:  678 697 1086 1042 436 420 98 106 170 147 49 71 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 84 31 

clinical_engagement 
diagnosis 
demography 
82 new agents 
261 
disease_progression 
H-positive risk:  696 673 105 1042 416 101 1094 433 150 71 170 49 
H-negative risk:  673 696 1094 1042 433 416 101 105 170 150 49 71 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 80 31 

clinical_engagement 
diagnosis 
demography 
76 new agents 
262 
disease_progression 
H-positive risk:  695 669 106 1056 411 99 1101 428 148 68 169 50 
H-negative risk:  669 695 1101 1056 428 411 99 106 169 148 50 68 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 79 31 

clinical_engagement 
diagnosis 
demography 
67 new agents 
263 
disease_progression 
H-positive risk:  697 660 105 1049 415 98 1097 440 152 66 170 51 
H-negative risk:  660 697 1097 1049 440 415 98 105 170 152 51 66 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 80 32 

clinical_engagement 
diagnosis 
demography 
86 new agents 
264 
disease_progression 
H-positive risk:  699 666 105 1045 418 97 1092 439 154 64 170 51 
H-negative risk:  666 699 1092 1045 439 418 97 105 170 154 51 64 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 80 30 

clinical_engagement 
diagnosis 
demography 
75 new agents 
265 
disease_progression 
H-positive risk:  707 664 104 1043 422 95 1086 439 153 61 176 50 
H-negative risk:  664 707 1086 1043 439 422 95 104 176 153 50 61 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 78 31 

clinical_engagement 
diagnosis 
demography 
88 new agents 
266 
disease_progression 
H-positive risk:  714 659 100 1044 427 91 1082 442 154 59 178 50 
H-negative risk:  659 714 1082 1044 442 427 91 100 178 154 50 59 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 77 30 

clinical_engagement 
diagnosis 
demography 
74 new agents 
267 
disease_progression 
H-positive risk:  718 648 99 1044 433 91 1086 442 154 60 175 50 
H-negative risk:  648 718 1086 1044 442 433 91 99 175 154 50 60 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 79 30 

clinical_engagement 
diagnosis 
demography 
71 new agents 
268 
disease_progression 
H-positive risk:  720 647 99 1046 429 91 1091 441 157 59 170 50 
H-negative risk:  647 720 1091 1046 441 429 91 99 170 157 50 59 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 81 33 

clinical_engagement 
diagnosis 
demography 
69 new agents 
269 
disease_progression 
H-positive risk:  720 652 98 1040 431 90 1089 447 153 59 171 50 
H-negative risk:  652 720 1089 1040 447 431 90 98 171 153 50 59 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 82 34 

clinical_engagement 
diagnosis 
demography 
74 new agents 
270 
disease_progression 
H-positive risk:  720 653 96 1039 432 90 1085 446 155 58 175 51 
H-negative risk:  653 720 1085 1039 446 432 90 96 175 155 51 58 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 83 33 

clinical_engagement 
diagnosis 
demography 
69 new agents 
271 
disease_progression 
H-positive risk:  719 660 94 1040 425 92 1085 443 153 57 175 57 
H-negative risk:  660 719 1085 1040 443 425 92 94 175 153 57 57 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 83 33 

clinical_engagement 
diagnosis 
demography 
85 new agents 
272 
disease_progression 
H-positive risk:  724 668 95 1039 425 94 1074 442 154 57 172 56 
H-negative risk:  668 724 1074 1039 442 425 94 95 172 154 56 57 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 80 33 

clinical_engagement 
diagnosis 
demography 
71 new agents 
273 
disease_progression 
H-positive risk:  728 660 97 1049 417 94 1069 445 158 54 170 59 
H-negative risk:  660 728 1069 1049 445 417 94 97 170 158 59 54 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 78 31 

clinical_engagement 
diagnosis 
demography 
77 new agents 
274 
disease_progression 
H-positive risk:  727 663 98 1054 423 95 1056 444 157 51 173 59 
H-negative risk:  663 727 1056 1054 444 423 95 98 173 157 59 51 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 80 32 

clinical_engagement 
diagnosis 
demography 
79 new agents 
275 
disease_progression 
H-positive risk:  724 656 98 1056 422 94 1062 446 159 51 175 57 
H-negative risk:  656 724 1062 1056 446 422 94 98 175 159 57 51 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 80 32 

clinical_engagement 
diagnosis 
demography 
60 new agents 
276 
disease_progression 
H-positive risk:  717 650 98 1059 431 95 1060 450 158 50 175 57 
H-negative risk:  650 717 1060 1059 450 431 95 98 175 158 57 50 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 82 31 

clinical_engagement 
diagnosis 
demography 
74 new agents 
277 
disease_progression 
H-positive risk:  705 658 97 1060 429 96 1063 449 157 51 179 56 
H-negative risk:  658 705 1063 1060 449 429 96 97 179 157 56 51 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 80 30 

clinical_engagement 
diagnosis 
demography 
84 new agents 
278 
disease_progression 
H-positive risk:  706 664 98 1063 423 96 1061 447 158 50 178 56 
H-negative risk:  664 706 1061 1063 447 423 96 98 178 158 56 50 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 79 29 

clinical_engagement 
diagnosis 
demography 
71 new agents 
279 
disease_progression 
H-positive risk:  707 665 96 1062 422 93 1062 450 160 51 175 57 
H-negative risk:  665 707 1062 1062 450 422 93 96 175 160 57 51 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 81 29 

clinical_engagement 
diagnosis 
demography 
65 new agents 
280 
disease_progression 
H-positive risk:  708 664 95 1065 424 95 1063 442 163 49 176 56 
H-negative risk:  664 708 1063 1065 442 424 95 95 176 163 56 49 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 81 29 

clinical_engagement 
diagnosis 
demography 
82 new agents 
281 
disease_progression 
H-positive risk:  694 660 94 1078 413 94 1079 443 164 48 176 57 
H-negative risk:  660 694 1079 1078 443 413 94 94 176 164 57 48 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 81 29 

clinical_engagement 
diagnosis 
demography 
71 new agents 
282 
disease_progression 
H-positive risk:  694 652 97 1078 407 93 1083 448 166 47 175 60 
H-negative risk:  652 694 1083 1078 448 407 93 97 175 166 60 47 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 83 29 

clinical_engagement 
diagnosis 
demography 
84 new agents 
283 
disease_progression 
H-positive risk:  693 658 98 1078 400 93 1083 443 169 47 178 60 
H-negative risk:  658 693 1083 1078 443 400 93 98 178 169 60 47 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 86 26 

clinical_engagement 
diagnosis 
demography 
82 new agents 
284 
disease_progression 
H-positive risk:  694 653 98 1075 397 90 1090 450 169 48 178 58 
H-negative risk:  653 694 1090 1075 450 397 90 98 178 169 58 48 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 87 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
285 
disease_progression 
H-positive risk:  696 664 97 1065 391 91 1089 449 169 49 182 58 
H-negative risk:  664 696 1089 1065 449 391 91 97 182 169 58 49 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 85 27 

clinical_engagement 
diagnosis 
demography 
89 new agents 
286 
disease_progression 
H-positive risk:  691 683 96 1066 379 91 1097 438 170 51 180 58 
H-negative risk:  683 691 1097 1066 438 379 91 96 180 170 58 51 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 88 27 

clinical_engagement 
diagnosis 
demography 
76 new agents 
287 
disease_progression 
H-positive risk:  688 683 97 1071 375 91 1094 442 167 51 182 59 
H-negative risk:  683 688 1094 1071 442 375 91 97 182 167 59 51 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 90 27 

clinical_engagement 
diagnosis 
demography 
77 new agents 
288 
disease_progression 
H-positive risk:  693 687 96 1072 372 91 1080 449 167 49 184 60 
H-negative risk:  687 693 1080 1072 449 372 91 96 184 167 60 49 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 89 26 

clinical_engagement 
diagnosis 
demography 
59 new agents 
289 
disease_progression 
H-positive risk:  693 689 97 1071 382 91 1076 440 171 49 184 57 
H-negative risk:  689 693 1076 1071 440 382 91 97 184 171 57 49 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 87 27 

clinical_engagement 
diagnosis 
demography 
99 new agents 
290 
disease_progression 
H-positive risk:  691 680 98 1083 386 93 1067 439 173 48 183 59 
H-negative risk:  680 691 1067 1083 439 386 93 98 183 173 59 48 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 86 27 

clinical_engagement 
diagnosis 
demography 
95 new agents 
291 
disease_progression 
H-positive risk:  697 679 98 1079 381 98 1072 433 171 49 185 58 
H-negative risk:  679 697 1072 1079 433 381 98 98 185 171 58 49 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 85 28 

clinical_engagement 
diagnosis 
demography 
81 new agents 
292 
disease_progression 
H-positive risk:  693 680 100 1068 388 100 1070 435 174 49 186 57 
H-negative risk:  680 693 1070 1068 435 388 100 100 186 174 57 49 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 83 28 

clinical_engagement 
diagnosis 
demography 
88 new agents 
293 
disease_progression 
H-positive risk:  693 680 98 1079 394 96 1061 435 172 51 183 58 
H-negative risk:  680 693 1061 1079 435 394 96 98 183 172 58 51 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 81 30 

clinical_engagement 
diagnosis 
demography 
63 new agents 
294 
disease_progression 
H-positive risk:  692 673 96 1076 397 92 1070 437 174 52 183 58 
H-negative risk:  673 692 1070 1076 437 397 92 96 183 174 58 52 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 83 29 

clinical_engagement 
diagnosis 
demography 
78 new agents 
295 
disease_progression 
H-positive risk:  691 672 97 1075 395 96 1080 429 175 50 183 57 
H-negative risk:  672 691 1080 1075 429 395 96 97 183 175 57 50 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
296 
disease_progression 
H-positive risk:  691 666 98 1080 396 97 1079 433 171 51 182 56 
H-negative risk:  666 691 1079 1080 433 396 97 98 182 171 56 51 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
297 
disease_progression 
H-positive risk:  684 661 97 1074 402 96 1088 436 170 50 183 59 
H-negative risk:  661 684 1088 1074 436 402 96 97 183 170 59 50 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
298 
disease_progression 
H-positive risk:  683 665 98 1081 393 99 1082 441 165 53 182 58 
H-negative risk:  665 683 1082 1081 441 393 99 98 182 165 58 53 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
98 new agents 
299 
disease_progression 
H-positive risk:  682 658 95 1084 391 104 1097 431 164 55 182 57 
H-negative risk:  658 682 1097 1084 431 391 104 95 182 164 57 55 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
62 new agents 
300 
disease_progression 
H-positive risk:  675 652 91 1085 389 104 1110 429 167 57 183 58 
H-negative risk:  652 675 1110 1085 429 389 104 91 183 167 58 57 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
301 
disease_progression 
H-positive risk:  671 655 91 1085 385 102 1121 430 162 56 183 59 
H-negative risk:  655 671 1121 1085 430 385 102 91 183 162 59 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
302 
disease_progression 
H-positive risk:  684 650 91 1093 382 100 1110 436 161 55 178 60 
H-negative risk:  650 684 1110 1093 436 382 100 91 178 161 60 55 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
92 new agents 
303 
disease_progression 
H-positive risk:  678 648 90 1094 384 100 1120 432 162 54 176 62 
H-negative risk:  648 678 1120 1094 432 384 100 90 176 162 62 54 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
85 new agents 
304 
disease_progression 
H-positive risk:  675 654 88 1097 390 101 1111 434 162 54 172 62 
H-negative risk:  654 675 1111 1097 434 390 101 88 172 162 62 54 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
305 
disease_progression 
H-positive risk:  679 659 87 1093 387 98 1112 435 164 56 169 61 
H-negative risk:  659 679 1112 1093 435 387 98 87 169 164 61 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
86 new agents 
306 
disease_progression 
H-positive risk:  673 661 85 1090 396 97 1120 429 164 55 167 63 
H-negative risk:  661 673 1120 1090 429 396 97 85 167 164 63 55 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 85 19 

clinical_engagement 
diagnosis 
demography 
75 new agents 
307 
disease_progression 
H-positive risk:  665 666 86 1094 395 96 1123 426 163 55 170 61 
H-negative risk:  666 665 1123 1094 426 395 96 86 170 163 61 55 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 87 19 

clinical_engagement 
diagnosis 
demography 
75 new agents 
308 
disease_progression 
H-positive risk:  659 664 88 1095 395 95 1126 430 159 54 174 61 
H-negative risk:  664 659 1126 1095 430 395 95 88 174 159 61 54 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 86 19 

clinical_engagement 
diagnosis 
demography 
77 new agents 
309 
disease_progression 
H-positive risk:  662 661 85 1097 389 95 1129 432 161 53 175 61 
H-negative risk:  661 662 1129 1097 432 389 95 85 175 161 61 53 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 86 18 

clinical_engagement 
diagnosis 
demography 
76 new agents 
310 
disease_progression 
H-positive risk:  663 665 85 1094 395 95 1131 427 159 53 174 59 
H-negative risk:  665 663 1131 1094 427 395 95 85 174 159 59 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 89 17 

clinical_engagement 
diagnosis 
demography 
76 new agents 
311 
disease_progression 
H-positive risk:  662 662 89 1092 399 92 1131 426 161 53 171 62 
H-negative risk:  662 662 1131 1092 426 399 92 89 171 161 62 53 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 93 14 

clinical_engagement 
diagnosis 
demography 
67 new agents 
312 
disease_progression 
H-positive risk:  669 658 88 1093 400 92 1125 429 162 52 170 62 
H-negative risk:  658 669 1125 1093 429 400 92 88 170 162 62 52 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 91 16 

clinical_engagement 
diagnosis 
demography 
65 new agents 
313 
disease_progression 
H-positive risk:  664 663 86 1094 405 92 1117 435 162 52 170 60 
H-negative risk:  663 664 1117 1094 435 405 92 86 170 162 60 52 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 89 16 

clinical_engagement 
diagnosis 
demography 
86 new agents 
314 
disease_progression 
H-positive risk:  659 660 88 1092 398 94 1119 451 156 52 171 60 
H-negative risk:  660 659 1119 1092 451 398 94 88 171 156 60 52 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 92 16 

clinical_engagement 
diagnosis 
demography 
90 new agents 
315 
disease_progression 
H-positive risk:  661 656 90 1101 392 92 1119 448 153 53 175 60 
H-negative risk:  656 661 1119 1101 448 392 92 90 175 153 60 53 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 91 16 

clinical_engagement 
diagnosis 
demography 
72 new agents 
316 
disease_progression 
H-positive risk:  656 659 90 1098 392 93 1122 447 151 53 176 63 
H-negative risk:  659 656 1122 1098 447 392 93 90 176 151 63 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 88 18 

clinical_engagement 
diagnosis 
demography 
66 new agents 
317 
disease_progression 
H-positive risk:  646 662 95 1091 396 94 1126 447 151 52 177 63 
H-negative risk:  662 646 1126 1091 447 396 94 95 177 151 63 52 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 85 19 

clinical_engagement 
diagnosis 
demography 
107 new agents 
318 
disease_progression 
H-positive risk:  640 673 95 1094 391 95 1127 443 149 52 178 63 
H-negative risk:  673 640 1127 1094 443 391 95 95 178 149 63 52 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
86 new agents 
319 
disease_progression 
H-positive risk:  642 675 95 1101 389 96 1127 439 146 52 175 63 
H-negative risk:  675 642 1127 1101 439 389 96 95 175 146 63 52 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
320 
disease_progression 
H-positive risk:  641 672 94 1096 391 96 1130 438 148 52 176 66 
H-negative risk:  672 641 1130 1096 438 391 96 94 176 148 66 52 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 78 28 

clinical_engagement 
diagnosis 
demography 
80 new agents 
321 
disease_progression 
H-positive risk:  629 679 92 1096 387 98 1132 434 147 58 182 66 
H-negative risk:  679 629 1132 1096 434 387 98 92 182 147 66 58 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 79 28 

clinical_engagement 
diagnosis 
demography 
86 new agents 
322 
disease_progression 
H-positive risk:  635 673 93 1096 382 99 1128 442 145 61 181 65 
H-negative risk:  673 635 1128 1096 442 382 99 93 181 145 65 61 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 77 27 

clinical_engagement 
diagnosis 
demography 
66 new agents 
323 
disease_progression 
H-positive risk:  635 664 94 1102 384 99 1128 438 144 63 183 66 
H-negative risk:  664 635 1128 1102 438 384 99 94 183 144 66 63 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 77 26 

clinical_engagement 
diagnosis 
demography 
70 new agents 
324 
disease_progression 
H-positive risk:  637 656 95 1108 383 103 1128 433 144 66 181 66 
H-negative risk:  656 637 1128 1108 433 383 103 95 181 144 66 66 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
325 
disease_progression 
H-positive risk:  637 657 93 1111 381 103 1116 445 146 66 180 65 
H-negative risk:  657 637 1116 1111 445 381 103 93 180 146 65 66 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
326 
disease_progression 
H-positive risk:  634 648 92 1120 384 103 1121 441 148 65 182 62 
H-negative risk:  648 634 1121 1120 441 384 103 92 182 148 62 65 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
327 
disease_progression 
H-positive risk:  626 644 95 1122 389 101 1125 443 150 65 180 60 
H-negative risk:  644 626 1125 1122 443 389 101 95 180 150 60 65 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
328 
disease_progression 
H-positive risk:  622 649 95 1123 387 104 1127 440 150 64 180 59 
H-negative risk:  649 622 1127 1123 440 387 104 95 180 150 59 64 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
329 
disease_progression 
H-positive risk:  623 649 96 1131 394 104 1116 440 149 61 176 61 
H-negative risk:  649 623 1116 1131 440 394 104 96 176 149 61 61 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
81 new agents 
330 
disease_progression 
H-positive risk:  628 649 95 1132 389 106 1116 444 148 59 171 63 
H-negative risk:  649 628 1116 1132 444 389 106 95 171 148 63 59 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
331 
disease_progression 
H-positive risk:  629 644 94 1128 392 104 1120 443 150 58 172 66 
H-negative risk:  644 629 1120 1128 443 392 104 94 172 150 66 58 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
332 
disease_progression 
H-positive risk:  624 650 89 1129 391 102 1125 443 148 58 174 67 
H-negative risk:  650 624 1125 1129 443 391 102 89 174 148 67 58 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
333 
disease_progression 
H-positive risk:  630 651 92 1128 400 98 1122 434 150 60 171 64 
H-negative risk:  651 630 1122 1128 434 400 98 92 171 150 64 60 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
70 new agents 
334 
disease_progression 
H-positive risk:  630 645 95 1123 405 98 1127 433 149 59 171 65 
H-negative risk:  645 630 1127 1123 433 405 98 95 171 149 65 59 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
335 
disease_progression 
H-positive risk:  628 643 94 1128 406 99 1124 441 151 57 168 61 
H-negative risk:  643 628 1124 1128 441 406 99 94 168 151 61 57 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
336 
disease_progression 
H-positive risk:  632 651 94 1125 406 99 1120 438 151 56 168 60 
H-negative risk:  651 632 1120 1125 438 406 99 94 168 151 60 56 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
337 
disease_progression 
H-positive risk:  626 643 94 1129 403 99 1134 432 152 58 169 61 
H-negative risk:  643 626 1134 1129 432 403 99 94 169 152 61 58 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
338 
disease_progression 
H-positive risk:  629 646 97 1128 400 101 1128 429 148 60 172 62 
H-negative risk:  646 629 1128 1128 429 400 101 97 172 148 62 60 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 76 20 

clinical_engagement 
diagnosis 
demography 
82 new agents 
339 
disease_progression 
H-positive risk:  627 651 98 1115 409 100 1135 424 145 64 172 60 
H-negative risk:  651 627 1135 1115 424 409 100 98 172 145 60 64 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
340 
disease_progression 
H-positive risk:  635 656 100 1115 407 101 1131 418 145 62 172 58 
H-negative risk:  656 635 1131 1115 418 407 101 100 172 145 58 62 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
68 new agents 
341 
disease_progression 
H-positive risk:  631 651 99 1120 408 100 1131 419 148 61 175 57 
H-negative risk:  651 631 1131 1120 419 408 100 99 175 148 57 61 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
96 new agents 
342 
disease_progression 
H-positive risk:  636 653 98 1118 408 102 1135 413 145 58 177 57 
H-negative risk:  653 636 1135 1118 413 408 102 98 177 145 57 58 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
343 
disease_progression 
H-positive risk:  643 652 99 1123 409 104 1127 411 140 62 174 56 
H-negative risk:  652 643 1127 1123 411 409 104 99 174 140 56 62 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
84 new agents 
344 
disease_progression 
H-positive risk:  636 650 101 1126 410 103 1133 412 141 61 168 59 
H-negative risk:  650 636 1133 1126 412 410 103 101 168 141 59 61 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
345 
disease_progression 
H-positive risk:  637 653 102 1123 404 104 1136 414 140 61 170 56 
H-negative risk:  653 637 1136 1123 414 404 104 102 170 140 56 61 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 70 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
346 
disease_progression 
H-positive risk:  633 654 104 1116 402 105 1135 427 136 65 168 55 
H-negative risk:  654 633 1135 1116 427 402 105 104 168 136 55 65 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 72 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
347 
disease_progression 
H-positive risk:  634 647 104 1116 408 103 1133 432 133 65 168 57 
H-negative risk:  647 634 1133 1116 432 408 103 104 168 133 57 65 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 75 26 

clinical_engagement 
diagnosis 
demography 
64 new agents 
348 
disease_progression 
H-positive risk:  637 642 106 1107 416 104 1137 428 133 68 163 59 
H-negative risk:  642 637 1137 1107 428 416 104 106 163 133 59 68 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 73 26 

clinical_engagement 
diagnosis 
demography 
68 new agents 
349 
disease_progression 
H-positive risk:  637 645 106 1106 415 104 1129 435 135 68 161 59 
H-negative risk:  645 637 1129 1106 435 415 104 106 161 135 59 68 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 74 27 

clinical_engagement 
diagnosis 
demography 
64 new agents 
350 
disease_progression 
H-positive risk:  639 645 107 1102 420 102 1122 439 140 66 157 61 
H-negative risk:  645 639 1122 1102 439 420 102 107 157 140 61 66 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 74 28 

clinical_engagement 
diagnosis 
demography 
72 new agents 
351 
disease_progression 
H-positive risk:  642 639 108 1101 419 105 1127 435 138 68 157 61 
H-negative risk:  639 642 1127 1101 435 419 105 108 157 138 61 68 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 77 28 

clinical_engagement 
diagnosis 
demography 
81 new agents 
352 
disease_progression 
H-positive risk:  645 647 107 1092 424 108 1121 437 135 67 155 62 
H-negative risk:  647 645 1121 1092 437 424 108 107 155 135 62 67 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 78 30 

clinical_engagement 
diagnosis 
demography 
93 new agents 
353 
disease_progression 
H-positive risk:  648 655 105 1089 415 108 1118 446 136 64 156 60 
H-negative risk:  655 648 1118 1089 446 415 108 105 156 136 60 64 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 75 28 

clinical_engagement 
diagnosis 
demography 
87 new agents 
354 
disease_progression 
H-positive risk:  661 656 109 1091 410 105 1115 441 137 65 152 58 
H-negative risk:  656 661 1115 1091 441 410 105 109 152 137 58 65 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 75 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
355 
disease_progression 
H-positive risk:  658 655 108 1086 414 103 1118 438 145 63 150 62 
H-negative risk:  655 658 1118 1086 438 414 103 108 150 145 62 63 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 77 26 

clinical_engagement 
diagnosis 
demography 
81 new agents 
356 
disease_progression 
H-positive risk:  659 649 111 1077 427 104 1122 433 147 65 147 59 
H-negative risk:  649 659 1122 1077 433 427 104 111 147 147 59 65 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
357 
disease_progression 
H-positive risk:  644 645 113 1087 425 102 1129 433 147 67 148 60 
H-negative risk:  645 644 1129 1087 433 425 102 113 148 147 60 67 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
81 new agents 
358 
disease_progression 
H-positive risk:  642 638 112 1099 421 104 1122 435 151 61 147 68 
H-negative risk:  638 642 1122 1099 435 421 104 112 147 151 68 61 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 81 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
359 
disease_progression 
H-positive risk:  645 644 110 1104 411 103 1117 441 152 58 148 67 
H-negative risk:  644 645 1117 1104 441 411 103 110 148 152 67 58 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
86 new agents 
360 
disease_progression 
H-positive risk:  638 647 108 1090 416 107 1125 440 152 61 149 67 
H-negative risk:  647 638 1125 1090 440 416 107 108 149 152 67 61 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
89 new agents 
Time difference of 17.13924 mins
This is task 21
date
